Cardiac assist devices (CAD) held one of the largest shares in congestive
heart failure treatment devices market due to the shortage of heart donors and technologically advanced cardiac assist devices in 2013.
This broader patent coverage can only increase the commercial value of our potential breakthrough approach to congestive
heart failure therapy.
We believe that all patients presenting to the emergency room with shortness of breath in which congestive
heart failure might be a cause should have this test performed," says Dr.
Such drugs would not only aid the people diagnosed with congestive
heart disease but might also rescue the hearts of many others who suffer from an early, undetected form of heart failure, says James B.
The most common signs of congestive
heart failure are swollen legs or ankles, difficulty in breathing, and weight gain because of accumulating fluid.
A snapshot of the global therapeutic scenario for Congestive
Heart Failure (Heart Failure).
Certain abnormalities or variations in the gene, when present, predict an individual's susceptibility to congestive
heart failure, one of the leading causes of sudden death.
Two new studies, though small in scope, suggest that exercise is as important for people with congestive
heart failure and those recovering from chemotherapy as it is for healthy people.
Global Markets Direct's, 'Congestive
Heart Failure (Heart Failure) - Pipeline Review, H1 2012', provides an overview of the Congestive
Heart Failure (Heart Failure) therapeutic pipeline.
com offers "Global Congestive
Heart Failure Drugs Market 2015-2019" of 120 pages new research report in its store.
In the United States alone, an estimated 3 million individuals--most of them over the age of 65--suffer from congestive
heart failure, the inability of the heart to pump out all of the blood that returns to it.
Heart Failure Partnering 2007-2012 provides understanding and access to the congestive
heart failure partnering deals and agreements entered into by the worlds leading healthcare companies.
GlobalData's clinical trial report, "Congestive
Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013" provides data on the Congestive
Heart Failure (Heart Failure) clinical trial scenario.
A blood-vessel-dilating drug can prolong the survival of persons suffering from congestive
heart failure, a chronic condition in which the heart's ability to pump is impaired, according to two independent groups of researchers.
Heart Failure Therapy Area Pipeline Report contains detailed information on the congestive
heart failure drug pipeline.